FDA 483 - Mandeep S. Oberoi, M.D. - January 10, 2020

Mandeep S. Oberoi, M.D., a clinical investigator in Elizabeth, NJ, was cited for one observation during an FDA inspection from December 2019 to January 2020. The inspection revealed a failure to retain investigational records for a study subject for the required period following drug marketing application approval. This indicates a lapse in record-keeping practices.